GENTIAN DIAGNOSTICS ASA (GENT.OL) Forecast, Price Target & Analyst Ratings

OSL:GENTNO0010748866

Current stock price

39.5 NOK
+0.5 (+1.28%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GENTIAN DIAGNOSTICS ASA (GENT.OL).

Forecast Snapshot

Consensus Price Target

Price Target
NOK64.26
+ 62.68% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
NOK64.26
Upside
+ 62.68%
From current price of NOK39.50 to mean target of NOK64.26, Based on 7 analyst forecasts
Low
NOK63.63
Median
NOK64.26
High
NOK66.15

Price Target Revisions

1 Month
0.00%
3 Months
-5.97%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for GENT.OL. The average price target is 64.26 NOK. This implies a price increase of 62.68% is expected in the next year compared to the current price of 39.5.
The average price target has been revised downward by 5.97% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

GENT Current Analyst RatingGENT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

GENT Historical Analyst RatingsGENT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
GENT.OL was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about GENT.OL.
In the previous month the buy percentage consensus was at a similar level.
GENT.OL was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
GENT.OL revenue by date.GENT.OL revenue by date.
135.153M
32.98%
152.069M
12.52%
176.499M
16.07%
220.32M
24.83%
269.28M
22.22%
311.1M
15.53%
EBITDA
YoY % growth
GENT.OL ebitda by date.GENT.OL ebitda by date.
2.381M
118.33%
24.686M
936.79%
34.567M
40.03%
58.14M
68.20%
82.62M
42.11%
98.94M
19.75%
EBIT
YoY % growth
GENT.OL ebit by date.GENT.OL ebit by date.
-7.185M
69.08%
15.723M
318.83%
25.452M
61.88%
44.88M
76.33%
69.36M
54.55%
80.58M
16.18%
Operating Margin
GENT.OL operating margin by date.GENT.OL operating margin by date.
-5.32%10.34%14.42%20.37%25.76%25.90%
EPS
YoY % growth
GENT.OL eps by date.GENT.OL eps by date.
N/A
85.33%
N/A
559.09%
N/A
-14.85%
2.67
204.65%
4.00
49.62%
5.05
26.28%

All data in NOK

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in NOK

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

GENT.OL Yearly Revenue VS EstimatesGENT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
GENT.OL Yearly EPS VS EstimatesGENT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
79.21%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
19.00%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
57.14%
EBIT Next 5 Year
N/A

GENTIAN DIAGNOSTICS ASA / GENT.OL Forecast FAQ

What do analysts expect the price target to be for GENTIAN DIAGNOSTICS ASA (GENT.OL)?

7 analysts have analysed GENT.OL and the average price target is 64.26 NOK. This implies a price increase of 62.68% is expected in the next year compared to the current price of 39.5.

Can you provide the consensus rating for GENTIAN DIAGNOSTICS ASA stock?

The consensus rating for GENTIAN DIAGNOSTICS ASA (GENT.OL) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.